0001209191-23-010915.txt : 20230217 0001209191-23-010915.hdr.sgml : 20230217 20230217191307 ACCESSION NUMBER: 0001209191-23-010915 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230215 FILED AS OF DATE: 20230217 DATE AS OF CHANGE: 20230217 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bekiroglu Elizabeth CENTRAL INDEX KEY: 0001884087 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40655 FILM NUMBER: 23644718 MAIL ADDRESS: STREET 1: 1616 EASTLAKE AVENUE E STREET 2: SUITE 208 CITY: SEATTLE STATE: WA ZIP: 98102-3793 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Icosavax, Inc. CENTRAL INDEX KEY: 0001786255 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1930 BOREN AVE., SUITE 1000 CITY: SEATTLE STATE: WA ZIP: 98101 BUSINESS PHONE: (206) 737-0085 MAIL ADDRESS: STREET 1: 1930 BOREN AVE., SUITE 1000 CITY: SEATTLE STATE: WA ZIP: 98101 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-02-15 0 0001786255 Icosavax, Inc. ICVX 0001884087 Bekiroglu Elizabeth C/O ICOSAVAX, INC. 1930 BOREN AVE., SUITE 1000 SEATTLE WA 98101 0 1 0 0 General Counsel & Corp. Sec. Stock Option (Right to Buy) 9.06 2023-02-15 4 A 0 100000 0.00 A 2033-02-14 Common Stock 100000 100000 D 25% of the shares subject to the option will vest on February 15, 2024, and 1/48th of the shares subject to the option vest monthly thereafter, subject to the reporting person's continued service through the applicable vesting date. /s/ Elizabeth Bekiroglu 2023-02-17